You are here:Home
»
Biochemicals
»
Biochem-Non-nucleoside Reverse Transcriptase
»
Etravirine
Pricing
For pricing information, USA customers sign in. Outside USA? Please contact your distributor for pricing. Specifications
| A novel HIV reverse transcriptase inhibitor useful in treatment of HIV infection. | | | Catalog # | 011878 | | Melting Point | As reported | | Solubility | As reported | | Method for Determining Identity | Proton NMR (DMSO-d6) Spectroscopic and Mass Spectrometric Analysis | | TLC Conditions | As reported | | Storage and Stability | May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. | | Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. | | Toxicity and Hazards | | | All products should be handled by qualified personnel only, trained in laboratory procedures. | | CAS Number | 269055-15-4 | | Molecular Formula | C20H15BrN6O | | Molecular Weight | 435.28 | | Purity | ~90% | | Form | As reported | | | Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. | | Alternate names | 4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl- |
External Links
|